SCHEMBL6137467

SCHEMBL6137467

O=C1Nc2ccc(Br)cc2C2CCCC12F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
LMNA P02545 2/20 0.39
PKM P14618 1/20 0.39
NOS3 P29474 3/20 0.38
NOS1 P29475 3/20 0.38
NOS2 P35228 3/20 0.38
TP53 P04637 2/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
LRRK2 Q5S007 1/20 0.34
NQO2 P16083 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137746 0.83 NOS3 (0.55) CYP2C19NOS3NOS1NOS2TP53
SCHEMBL6137673 0.83 NOS3 (0.35) POLBCYP3A4CYP2C19LMNANOS3
SCHEMBL6137634 0.80 NOS3 (0.48) POLBNOS3NOS1NOS2KMT2A
SCHEMBL7171088 0.72 HTT (0.37) POLBCYP2C19NOS3NOS1NOS2
SCHEMBL6137774 0.72 NOS3 (0.39) POLBCYP3A4CYP2C19NOS3NOS1
SCHEMBL6137334 0.71 NOS3 (0.72) NOS3NOS1NOS2
SCHEMBL6137525 0.70 NOS3 (0.41) POLBCYP3A4CYP2C19NOS3NOS1
SCHEMBL6137662 0.69 NOS3 (0.34) CYP3A4LMNANOS3NOS1NOS2
SCHEMBL6137625 0.69 NOS3 (0.40) NOS3NOS1NOS2
SCHEMBL6137677 0.68 TDP2 (0.39) NOS3NOS1NOS2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1129077-B9 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-07-20 EP disclosed
EP-1129077-B1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-04-20 EP disclosed
US-6579883-B1 Nitrogen monoxide synthases; 4-amino-8-bromo-3a-fluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta (c) quinoline; neurodegenerative, autoimmune, cardiovascular diseases SCHERING AKTIENGESELLSCHAFT (DE) 2003-06-17 US disclosed
EP-1129077-A1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2001-09-05 EP disclosed
WO-2000029381-A1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2000-05-25 WO disclosed